Table 4 The screening criteria for correlation analysis and significant results display for each group
Feature Analysed | Sex | Age | Smoking | Pathotype | Stage | |
|---|---|---|---|---|---|---|
Screening Critiria | Sex | 30 for each sex | Female | Male | Male | Female |
Age | 30–65 | 33–78, median 59 | 30–65 | 30–65 | 30–65 | |
Smoking | Never | Never | Never23, Smoking 29 | Never | Never | |
Pathotype | Aden | Aden | Aden | Aden 30, Squa 30 | Aden | |
Stage | I | III | I | III | 15 for each stage | |
Significant Blood Features (rs*) | MCHC(-0.4284), WRPI (-0.323) | API (0.536), FIB4 (0.543) | Neu (-0.3608), AISI (-0.3524), AAR (0.3973), NER (-0.3693), NLPR (-0.3496), NP (-0.3468), NP (-0.3468), SII (-0.3496), COP_NLR (-0.3615) | None | ALRI (0.3334), GGLR (0.4041), GPR (0.343), HII (-0.3205), LMR (-0.3513), NHL (0.3343), SIM (0.3196), PNI_APRI (0.3421) | |